US-based Calidi Biotherapeutics announces research collaboration with the NIH

US-based clinical-stage biotechnology company Calidi Biotherapeutics collaborates with National Institutes of Health on the therapeutic potential of oncolytic viruses delivered by mesenchymal stem cells.



  • Calidi Biotherapeutics collaborates with NIH on clinical research